title: A PBPK workflow for first-in-human dose selection of a subcutaneously administered pegylated peptide.
abstract: Predicting the pharmacokinetic (PK) time course of a subcutaneously (SC) administered novel therapeutic protein using in silico approaches offers an opportunity to streamline the drug development process by facilitating selection of starting and target doses in initial human trials. Herein, we propose a workflow for predicting the human exposure time course following SC administration. Leveraging knowledge obtained following both intravenous and SC administration in monkeys, this workflow employs the development of a whole body physiologically-based pharmacokinetic (PBPK) model incorporating vascular circulation, lymphatic uptake and both renal and non-specific clearance mechanisms to predict the PK of a novel pegylated peptide. Optimization of the model was initially performed in monkeys, after which the model was scaled up to human proportion. Inclusion of a SC depot compartment allowed for precise simulation of the SC time course in monkeys. Simulated human exposure after SC administration was within approximately 20 % of the observed values and successfully predicted the time course of two subsequent dosing levels. This workflow represents one of the first publications of a PBPK workflow to predict the time course of a SC administered therapeutic protein based off of a single, non-human primate species and shows promise in facilitating the dose selection in first-in-human dose escalation studies for novel protein therapeutics.
authors: School of Pharmacy, University of Waterloo, 200 University Ave W, Waterloo, ON, N2L 3G1, Canada, eoffman@uwaterloo.ca.
authors: Elliot
authors: E
authors: Offman
authors: Andrea N
authors: AN
authors: Edginton
mesh_terms: D000818:Animals; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous / Q000379:methods; D008252:Macaca fascicularis; D008954:Models, Biological; D010455:Peptides / Q000008:administration & dosage*; D057188:Workflow
chemical_list: D010455:Peptides
references: J Clin Pharmacol. 2009 Dec;49(12):1382-402
references: 19837907
references: Drug Discov Today. 2014 Oct;19(10):1623-31
references: 24929223
references: Clin Pharmacokinet. 2011 Feb;50(2):131-42
references: 21241072
references: J Pharmacokinet Pharmacodyn. 2012 Feb;39(1):67-86
references: 22143261
references: Xenobiotica. 2013 Jun;43(6):561-9
references: 23244626
references: J Pharmacokinet Pharmacodyn. 2007 Oct;34(5):687-709
references: 17636457
references: J Angiogenes Res. 2010 Aug 11;2:14
references: 20701757
references: Acta Physiol Scand. 1987 Nov;131(3):411-28
references: 3321914
references: Mol Pharm. 2014 Feb 3;11(2):496-504
references: 24350780
references: Physiol Rev. 1994 Jan;74(1):163-219
references: 8295933
references: Nat Rev Drug Discov. 2014 Aug;13(8):622-38
references: 25011539
references: Ann Biomed Eng. 2005 Nov;33(11):1640-52
references: 16341929
references: Pharm Res. 1993 Jul;10(7):1093-5
references: 8378254
references: J Clin Pharmacol. 2013 Mar;53(3):314-25
references: 23426855
references: MAbs. 2012 Mar-Apr;4(2):243-55
references: 22453096
references: MAbs. 2011 Jan-Feb;3(1):61-6
references: 20962582
references: Adv Drug Deliv Rev. 2001 Aug 23;50(1-2):3-20
references: 11489331
references: Drug Metab Dispos. 2012 May;40(5):952-62
references: 22328584
references: Drug Metab Dispos. 2013 Jan;41(1):248-55
references: 23129212
references: J Pharmacokinet Pharmacodyn. 2012 Feb;39(1):37-54
references: 22161221
references: Biopharm Drug Dispos. 2010 May;31(4):253-63
references: 20437464
references: J Vet Med Sci. 2014 Oct;76(10 ):1423-6
references: 24998395
references: Drug Metab Dispos. 2013 Apr;41(4):774-84
references: 23318685
references: Pharm Res. 1990 Feb;7(2):167-9
references: 2137911
references: AAPS J. 2012 Sep;14(3):559-70
references: 22619041
references: Nat Rev Immunol. 2003 Jan;3(1):23-35
references: 12511873
references: Drug Metab Dispos. 2007 Sep;35(9):1672-8
references: 17576810
references: Pharm Res. 1988 Aug;5(8):472-6
references: 3244653
references: J Mass Spectrom. 2001 Sep;36(9):1038-52
references: 11599082
references: Adv Drug Deliv Rev. 2003 Sep 26;55(10):1261-77
references: 14499706
references: Cancer Res. 1995 Oct 15;55(20):4611-22
references: 7553638
references: Biotechnol Bioeng. 2008 Dec 15;101(6):1214-22
references: 18980182
references: Int Immunopharmacol. 2008 Mar;8(3):401-13
references: 18279794
references: J Pharmacol Exp Ther. 1998 Nov;287(2):457-68
references: 9808668